Tech Company Financing Transactions
Cebix Funding Round
InterWest Partners, Sofinnova Ventures, Thomas and McNerny & Partners joined a $30.9 million Series B funding round for Cebix. This venture round was recorded on 10/18/2012.
Transaction Overview
Company Name
Announced On
10/18/2012
Transaction Type
Venture Equity
Amount
$30,900,000
Round
Series B
Investors
Proceeds Purpose
The Series B proceeds will fully fund the company through the Phase 2b trial.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1298 Prospect St. 2A
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joel Martin
Chief Medical Officer
Dennis Kim
Chief Scientific Officer
John Wahren
VP - Regulatory Affairs
Michelle Mazzoni
Browse more venture capital transactions:
Prev: 10/18/2012: Spring Mobile Solutions venture capital transaction
Next: 10/18/2012: LocalVox venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs